Scandinavian Medical Solutions AS (SMSMED) — Cash Flow Reinvestment Rate
Scandinavian Medical Solutions AS (SMSMED) has a Cash Flow Reinvestment Rate of 0.85x as of September 2024, reinvesting Dkr15.13 Million (capex Dkr15.13 Million ) from operating cash flow of Dkr17.86 Million. See cash generation quality of Scandinavian Medical Solutions AS to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Scandinavian Medical Solutions AS Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Scandinavian Medical Solutions AS across 3 annual periods. For the full cash flow conversion analysis, see SMSMED cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Scandinavian Medical Solutions AS (2020–2024)
Year-by-year capital reinvestment analysis for Scandinavian Medical Solutions AS. See Scandinavian Medical Solutions AS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.53x | Dkr18.77 Million | Dkr3.39 Million | Dkr18.47 Million | ▲ +8193.5% |
| 2021 | 0.07x | Dkr268.50K | Dkr4.02 Million | Dkr5.00 | ▼ -95.5% |
| 2020 | 1.47x | Dkr13.79 Million | Dkr9.38 Million | Dkr13.76 Million | — |